ARKEMA (AKE.PA) Stock Fundamental Analysis
Europe - EPA:AKE - FR0010313833 - Common Stock
52.25 EUR
-1.15 (-2.15%)
We assign a fundamental rating of 5 out of 10 to AKE. AKE was compared to 69 industry peers in the Chemicals industry. Both the profitability and the financial health of AKE get a neutral evaluation. Nothing too spectacular is happening here. AKE has a valuation in line with the averages, but on the other hand it scores bad on growth.
1. Profitability
1.1 Basic Checks
In the past year AKE was profitable.
AKE had a positive operating cash flow in the past year.
AKE had positive earnings in each of the past 5 years.
In the past 5 years AKE always reported a positive cash flow from operatings.
1.2 Ratios
The Return On Assets of AKE (1.51%) is comparable to the rest of the industry.
AKE has a Return On Equity (2.90%) which is in line with its industry peers.
AKE has a Return On Invested Capital of 3.44%. This is comparable to the rest of the industry: AKE outperforms 52.24% of its industry peers.
The Average Return On Invested Capital over the past 3 years for AKE is in line with the industry average of 6.77%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.51% | ||
| ROE | 2.9% | ||
| ROIC | 3.44% |
ROA(3y)4.01%
ROA(5y)5.07%
ROE(3y)7.69%
ROE(5y)9.89%
ROIC(3y)5.57%
ROIC(5y)5.74%
1.3 Margins
AKE has a Profit Margin (2.22%) which is in line with its industry peers.
In the last couple of years the Profit Margin of AKE has declined.
AKE has a Operating Margin of 6.35%. This is comparable to the rest of the industry: AKE outperforms 59.70% of its industry peers.
In the last couple of years the Operating Margin of AKE has declined.
With a Gross Margin value of 19.02%, AKE is not doing good in the industry: 71.64% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of AKE has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 6.35% | ||
| PM (TTM) | 2.22% | ||
| GM | 19.02% |
OM growth 3Y-14.88%
OM growth 5Y-6.39%
PM growth 3Y-36.12%
PM growth 5Y-8.82%
GM growth 3Y-3.36%
GM growth 5Y-1.36%
2. Health
2.1 Basic Checks
AKE has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
AKE has more shares outstanding than it did 1 year ago.
AKE has less shares outstanding than it did 5 years ago.
AKE has a worse debt/assets ratio than last year.
2.2 Solvency
AKE has an Altman-Z score of 1.87. This is not the best score and indicates that AKE is in the grey zone with still only limited risk for bankruptcy at the moment.
The Altman-Z score of AKE (1.87) is worse than 67.16% of its industry peers.
AKE has a debt to FCF ratio of 16.70. This is a negative value and a sign of low solvency as AKE would need 16.70 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 16.70, AKE is in line with its industry, outperforming 59.70% of the companies in the same industry.
AKE has a Debt/Equity ratio of 0.50. This is a neutral value indicating AKE is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.50, AKE is in line with its industry, outperforming 41.79% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.5 | ||
| Debt/FCF | 16.7 | ||
| Altman-Z | 1.87 |
ROIC/WACC0.71
WACC4.86%
2.3 Liquidity
AKE has a Current Ratio of 2.73. This indicates that AKE is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of AKE (2.73) is better than 79.10% of its industry peers.
A Quick Ratio of 1.92 indicates that AKE should not have too much problems paying its short term obligations.
AKE has a Quick ratio of 1.92. This is amongst the best in the industry. AKE outperforms 82.09% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.73 | ||
| Quick Ratio | 1.92 |
3. Growth
3.1 Past
The earnings per share for AKE have decreased strongly by -38.27% in the last year.
Measured over the past 5 years, AKE shows a small growth in Earnings Per Share. The EPS has been growing by 0.10% on average per year.
The Revenue has been growing slightly by 0.32% in the past year.
AKE shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 1.78% yearly.
EPS 1Y (TTM)-38.27%
EPS 3Y-11.49%
EPS 5Y0.1%
EPS Q2Q%-54.21%
Revenue 1Y (TTM)0.32%
Revenue growth 3Y0.09%
Revenue growth 5Y1.78%
Sales Q2Q%-7.55%
3.2 Future
AKE is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -1.61% yearly.
AKE is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.08% yearly.
EPS Next Y-35.91%
EPS Next 2Y-13.74%
EPS Next 3Y-4.81%
EPS Next 5Y-1.61%
Revenue Next Year-4.84%
Revenue Next 2Y-1.36%
Revenue Next 3Y0.39%
Revenue Next 5Y2.08%
3.3 Evolution
The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 10.13, which indicates a very decent valuation of AKE.
94.03% of the companies in the same industry are more expensive than AKE, based on the Price/Earnings ratio.
When comparing the Price/Earnings ratio of AKE to the average of the S&P500 Index (25.89), we can say AKE is valued rather cheaply.
Based on the Price/Forward Earnings ratio of 8.55, the valuation of AKE can be described as reasonable.
Based on the Price/Forward Earnings ratio, AKE is valued cheaply inside the industry as 95.52% of the companies are valued more expensively.
When comparing the Price/Forward Earnings ratio of AKE to the average of the S&P500 Index (34.59), we can say AKE is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.13 | ||
| Fwd PE | 8.55 |
4.2 Price Multiples
AKE's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. AKE is cheaper than 94.03% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, AKE is valued a bit cheaper than 79.10% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 17.51 | ||
| EV/EBITDA | 4.48 |
4.3 Compensation for Growth
AKE's earnings are expected to decrease with -4.81% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)103.61
EPS Next 2Y-13.74%
EPS Next 3Y-4.81%
5. Dividend
5.1 Amount
AKE has a Yearly Dividend Yield of 6.74%, which is a nice return.
Compared to an average industry Dividend Yield of 3.36, AKE pays a better dividend. On top of this AKE pays more dividend than 91.04% of the companies listed in the same industry.
AKE's Dividend Yield is rather good when compared to the S&P500 average which is at 2.44.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 6.74% |
5.2 History
On average, the dividend of AKE grows each year by 6.86%, which is quite nice.
Dividend Growth(5Y)6.86%
Div Incr Years4
Div Non Decr Years4
5.3 Sustainability
129.52% of the earnings are spent on dividend by AKE. This is not a sustainable payout ratio.
The Dividend Rate of AKE has been growing, while earnings will be declining. This means the dividend growth is most likely not sustainable.
DP129.52%
EPS Next 2Y-13.74%
EPS Next 3Y-4.81%
EPA:AKE (11/14/2025, 7:00:00 PM)
52.25
-1.15 (-2.15%)
Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)
Earnings (Next)
Inst Owners59.49%
Inst Owner ChangeN/A
Ins Owners0.58%
Ins Owner ChangeN/A
Market Cap3.97B
Revenue(TTM)9.54B
Net Income(TTM)210.00M
Analysts73.33
Price Target71.27 (36.4%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 6.74% |
Yearly Dividend3.47
Dividend Growth(5Y)6.86%
DP129.52%
Div Incr Years4
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-7.64%
Min EPS beat(2)-8.67%
Max EPS beat(2)-6.61%
EPS beat(4)0
Avg EPS beat(4)-8.86%
Min EPS beat(4)-18.44%
Max EPS beat(4)-1.73%
EPS beat(8)3
Avg EPS beat(8)-4.83%
EPS beat(12)7
Avg EPS beat(12)1.09%
EPS beat(16)11
Avg EPS beat(16)10.55%
Revenue beat(2)0
Avg Revenue beat(2)-0.69%
Min Revenue beat(2)-0.92%
Max Revenue beat(2)-0.46%
Revenue beat(4)0
Avg Revenue beat(4)-1.13%
Min Revenue beat(4)-2.56%
Max Revenue beat(4)-0.46%
Revenue beat(8)2
Avg Revenue beat(8)-0.53%
Revenue beat(12)4
Avg Revenue beat(12)-0.93%
Revenue beat(16)8
Avg Revenue beat(16)0.76%
PT rev (1m)-8.22%
PT rev (3m)-10.42%
EPS NQ rev (1m)-4.68%
EPS NQ rev (3m)-32.06%
EPS NY rev (1m)-7.1%
EPS NY rev (3m)-34.13%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-4.07%
Revenue NY rev (1m)-1.12%
Revenue NY rev (3m)-2.7%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.13 | ||
| Fwd PE | 8.55 | ||
| P/S | 0.42 | ||
| P/FCF | 17.51 | ||
| P/OCF | 3.91 | ||
| P/B | 0.55 | ||
| P/tB | 1.86 | ||
| EV/EBITDA | 4.48 |
EPS(TTM)5.16
EY9.88%
EPS(NY)6.11
Fwd EY11.69%
FCF(TTM)2.98
FCFY5.71%
OCF(TTM)13.36
OCFY25.57%
SpS124.15
BVpS95.11
TBVpS28.16
PEG (NY)N/A
PEG (5Y)103.61
Graham Number105.08
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.51% | ||
| ROE | 2.9% | ||
| ROCE | 4.88% | ||
| ROIC | 3.44% | ||
| ROICexc | 3.86% | ||
| ROICexgc | 7.22% | ||
| OM | 6.35% | ||
| PM (TTM) | 2.22% | ||
| GM | 19.02% | ||
| FCFM | 2.4% |
ROA(3y)4.01%
ROA(5y)5.07%
ROE(3y)7.69%
ROE(5y)9.89%
ROIC(3y)5.57%
ROIC(5y)5.74%
ROICexc(3y)6.56%
ROICexc(5y)6.98%
ROICexgc(3y)13.06%
ROICexgc(5y)13.27%
ROCE(3y)8.13%
ROCE(5y)8.28%
ROICexgc growth 3Y-19.33%
ROICexgc growth 5Y-9.22%
ROICexc growth 3Y-22.98%
ROICexc growth 5Y-11.22%
OM growth 3Y-14.88%
OM growth 5Y-6.39%
PM growth 3Y-36.12%
PM growth 5Y-8.82%
GM growth 3Y-3.36%
GM growth 5Y-1.36%
F-Score5
Asset Turnover0.68
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.5 | ||
| Debt/FCF | 16.7 | ||
| Debt/EBITDA | 2.56 | ||
| Cap/Depr | 95.75% | ||
| Cap/Sales | 8.36% | ||
| Interest Coverage | 17.14 | ||
| Cash Conversion | 71.35% | ||
| Profit Quality | 108.1% | ||
| Current Ratio | 2.73 | ||
| Quick Ratio | 1.92 | ||
| Altman-Z | 1.87 |
F-Score5
WACC4.86%
ROIC/WACC0.71
Cap/Depr(3y)97.52%
Cap/Depr(5y)93.37%
Cap/Sales(3y)7.14%
Cap/Sales(5y)7.42%
Profit Quality(3y)111.66%
Profit Quality(5y)102.9%
High Growth Momentum
Growth
EPS 1Y (TTM)-38.27%
EPS 3Y-11.49%
EPS 5Y0.1%
EPS Q2Q%-54.21%
EPS Next Y-35.91%
EPS Next 2Y-13.74%
EPS Next 3Y-4.81%
EPS Next 5Y-1.61%
Revenue 1Y (TTM)0.32%
Revenue growth 3Y0.09%
Revenue growth 5Y1.78%
Sales Q2Q%-7.55%
Revenue Next Year-4.84%
Revenue Next 2Y-1.36%
Revenue Next 3Y0.39%
Revenue Next 5Y2.08%
EBIT growth 1Y-21.16%
EBIT growth 3Y-14.81%
EBIT growth 5Y-4.73%
EBIT Next Year49.9%
EBIT Next 3Y20.73%
EBIT Next 5Y12.81%
FCF growth 1Y-64.53%
FCF growth 3Y33.3%
FCF growth 5Y-10.84%
OCF growth 1Y-26.48%
OCF growth 3Y7%
OCF growth 5Y-2.92%
ARKEMA / AKE.PA FAQ
What is the ChartMill fundamental rating of ARKEMA (AKE.PA) stock?
ChartMill assigns a fundamental rating of 5 / 10 to AKE.PA.
What is the valuation status of ARKEMA (AKE.PA) stock?
ChartMill assigns a valuation rating of 6 / 10 to ARKEMA (AKE.PA). This can be considered as Fairly Valued.
How profitable is ARKEMA (AKE.PA) stock?
ARKEMA (AKE.PA) has a profitability rating of 4 / 10.
What are the PE and PB ratios of ARKEMA (AKE.PA) stock?
The Price/Earnings (PE) ratio for ARKEMA (AKE.PA) is 10.13 and the Price/Book (PB) ratio is 0.55.
How financially healthy is ARKEMA?
The financial health rating of ARKEMA (AKE.PA) is 5 / 10.